drug
as of 2026-07-01Left Active Repetitive transcranial magnetic stimulation (rTMS)
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Shanghai Mental Health Center
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DEVICE
Indications
Trials
1
Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia
NCT05599373—Unknown
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here